Assetmark, Inc Invitae Corp Transaction History

Assetmark, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$7.64 - $27.5 $565 - $2,035	-74 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$15.02 - $20.57 $165 - $226	11 Added 17.46%	74 $1,000
Q3 2019 Nov 13, 2019	BUY	$18.85 - $27.5 $546 - $797	29 Added 85.29%	63 $1,000
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $156 - $236	9 Added 36.0%	34 $1,000
Q1 2019 May 14, 2019	BUY	$10.65 - $25.75 $266 - $643	25 New	25 $1,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.